BIPH - They should be getting closer to striking a licensing deal with Boston Scientific. The CEO has also said in recent interviews they're getting closer to striking an equity investment deal with one of their partners to replace the SBI financing that was announced this spring. During the annual shareholder meeting the CEO said that the first tranche of the SBI financing was in process, but that they are being judicious while waiting to strike an equity deal with a strategic partner.
Considering the SBI financing was at an average of $1.41/share, hopefully they can reel in a partner for similar or better terms, despite the current PPS?
There's not many OTC CEOs that I trust, but Mike Weiner is proving himself to be a man of his word.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
